GONAPEPTYL

This brand name is authorized in Brazil, Finland, France, Ireland, Mexico, Netherlands, Poland, Romania, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug GONAPEPTYL contains one active pharmaceutical ingredient (API):

1	Triptorelin UNII 43OFW291R9 - TRIPTORELIN ACETATE
	Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins.
	Read more about Triptorelin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GONAPEPTYL DEPOT Powder and solvent for suspension for injection prolonged release	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02AE04	Triptorelin	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	521400401155410, 521401501153418
ES	Centro de información online de medicamentos de la AEMPS	64530
FI	Lääkealan turvallisuus- ja kehittämiskeskus	099733
FR	Base de données publique des médicaments	68628809
GB	Medicines & Healthcare Products Regulatory Agency	56158
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	020M2018, 376M2008
NL	Z-Index G-Standaard, PRK	70084
PL	Rejestru Produktów Leczniczych	100210734
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W58059001, W58059002
TN	Direction de la Pharmacie et du Médicament	5523061
TR	İlaç ve Tıbbi Cihaz Kurumu	8697621950528, 8697621950764
ZA	Health Products Regulatory Authority	37/21.10/0408